Bought back recently sold Pfizer shares and then some. Tariff saga continues but there are at least minor hints of reversal in some areas. We haven’t seen any pharma specific insanities on top of the normal ones. Considering all this – and the fact that Pfizer reported somewhat decent results today – I decided to buy 400 shares for 22,70 USD per share. This doubles my original position but risks are still there: Trump might trump any trade and long term positioning of Pfizer has plenty of risks. Let’s see how this eventually plays out.